-
1st generation
stem cellsHigh purity and high efficacy using original technology stem cell therapy
-
2nd generation
stem cellsIntroduction of priming technology1st-generation stem cells stimulate the immune environment A treatment that enhances the function
-
3rd generation
stem cellsEfficacy gene insertionStem cells have therapeutic properties A therapeutic agent with increased efficacy by inserting a gene
The development of the 1st generation stem cell therapy has been completed.
The 2nd generation has been completed in the research phase and clinical treatment is under the processing.
The research of the 3rd generation is being carried out.
The development of induced pluripotent stem cell-derived pancreatic beta-cell treatment is being conducted in cooperation with Allele Biotechnology in the United States, and the development of muscle cell treatment is participating in the U.S. Vita Therapeutics as an equity investment.
Source: Dr. Teruo Okano, CSTEC at the University of Utah
Using a temperature-sensitive polymer, the stem cells are made in the form of a sheet,
A therapeutic agent that is attached to organs or tissues to exert anti-fibrotic properties
Differentiate the patient's immune cells into dendritic cells, and extract them from the patient's cancer tissue.
A therapeutic agent made by inserting the isolated mRNA and CD40L mRNA
(Pievani et al, Blood, 2011)
A treatment made by inserting the Chimera Antigen Receptor (CAR) gene into Cytokine Induced Killer (CIK) made by stimulating cord blood-derived immune cells with cytokines